N-[4-amino-6-oxo-2-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1H-pyrimidin-5-yl]-5-bromofuran-2-carboxamide
C20H20BrN5O4S — CID 135705924
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-amino-6-oxo-2-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1H-pyrimidin-5-yl]-5-bromofuran-2-carboxamide
N-[4-amino-6-oxo-2-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1H-pyrimidin-5-yl]-5-bromofuran-2-carboxamide (PubChem CID 135705924) has the molecular formula C20H20BrN5O4S and a molecular weight of 506.38 g/mol. Its IUPAC name is N-[4-amino-6-oxo-2-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1H-pyrimidin-5-yl]-5-bromofuran-2-carboxamide.
Molecular Properties
| Compound Name | N-[4-amino-6-oxo-2-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1H-pyrimidin-5-yl]-5-bromofuran-2-carboxamide |
|---|---|
| PubChem CID | 135705924 |
| Molecular Formula | C20H20BrN5O4S |
| Molecular Weight | 506.38 g/mol |
| Exact Mass | 505.04 |
| IUPAC Name | N-[4-amino-6-oxo-2-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1H-pyrimidin-5-yl]-5-bromofuran-2-carboxamide |
| SMILES | Cc1cc(C)c(NC(=O)CSc2nc(N)c(NC(=O)c3ccc(Br)o3)c(=O)[nH]2)c(C)c1 |
| InChI | InChI=1S/C20H20BrN5O4S/c1-9-6-10(2)15(11(3)7-9)23-14(27)8-31-20-25-17(22)16(19(29)26-20)24-18(28)12-4-5-13(21)30-12/h4-7H,8H2,1-3H3,(H,23,27)(H,24,28)(H3,22,25,26,29) |
| InChIKey | DGKHVXRPZZJYIN-UHFFFAOYSA-N |
| XLogP | 3.62 |
| TPSA | 143.11 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.38 |
| LogP ≤ 5 | 3.62 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135705924 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.